Remove Medicine Remove Patients Remove Treatment Remove Workshop
article thumbnail

Every New Jersey Dispensary That MMJ Patients Need To Know

MMJ Recs

With a growing number of New Jersey MMJ dispensaries offering a wide range of cannabis products, it’s essential for MMJ patients to stay informed about the options available. Patients can now access a wide variety of cannabis products to address their medical needs. They offer a variety of strains and product options.

article thumbnail

Tilray Says It Is Expanding Medical Cannabis Activity In Australia

Cannabis Law Report

says it is expanding its medical cannabis product offerings for patients and related education for health professionals in Australia. Previously, only cannabis extract products such as cannabidiol (CBD) were available to Australian patients. treatment considerations, dosing and titration. patient management and legislation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Every California Dispensary That MMJ Patients Need To Know

MMJ Recs

California has been a trailblazer in the realm of medical marijuana, offering patients access to a variety of treatment options. Patients must first schedule an appointment with a licensed medical professional who can evaluate their medical history and condition. In 1996, the state became the first in the U.S.

article thumbnail

The Economic Impact of the Medical Marijuana Industry: Trends and Projections

MMJ Recs

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Market size refers to the total value of medical cannabis sales, encompassing both medicinal and adult-use markets.

article thumbnail

Psychedelics Go To Davos…

Cannabis Law Report

A recent publication in the prominent peer-reviewed journal Nature, shows that 67% of patients no longer qualified for a PTSD diagnosis a year after treatment with MDMA (or “ecstasy”). The clinical evidence for psychedelic assisted therapy is accumulating.

article thumbnail

What Makes CannMed Unique and Why You Don’t Want to Miss It

Medicinal Genomics

CannMed started in 2016, when Medicinal Genomics partnered with Dr. Raphael Mechoulam to host the leading researchers and clinicians in cannabinoid medicine at Boston’s Harvard Medical School. In 2023, CannMed transformed into an Innovation and Investment Summit held at the J.W. Marriott Marco Island Beach Resort, Marco Island, FL.

article thumbnail

Breaking the Stigma: Shifting Attitudes Toward Medical Marijuana Nationwide

MMJ Recs

The AIDS epidemic in the 1980s brought attention to the potential benefits of marijuana in alleviating symptoms such as nausea and appetite loss associated with the disease and its treatment. Another influential factor is the growing emphasis on individual autonomy and patient choice in healthcare.